BACKGROUND: Acute coagulopathy of trauma (ACOT) has been described as a very early hypocoagulable state, but the mechanism remains controversial. One proposed mechanism is tissue hypoperfusion leading to protein C activation, with subsequent inhibition of Factors V and VIII. Variability in trauma has impeded the use of clinical data towards the elucidation of the mechanisms of ACOT, but thrombelastography (TEG) may provide insight by assessing hemostatic function from initial thrombin activation to fibrinolysis. We hypothesized that in a controlled animal model of trauma/hemorrhagic shock, clotting factor dysfunction is the predominant mechanism in early ACOT. METHODS: Rats anesthetized by inhaled isoflurane (n = 6) underwent laparotomy, and hemorrhage was induced to maintain a MAP of 35 mm Hg for 30 min. Rats were then resuscitated with twice their shed blood volume in normal saline. TEG was performed at baseline, shock, and post-resuscitation periods. No heparin was given. Statistical analysis was performed by ANOVA with post-hoc Fisher's test. RESULTS: Coagulation factor function was significantly impaired in the early stages of trauma/hemorrhagic shock. TEG R and SP-values were significantly increased from baseline to shock (P < 0.001) and from shock to post-resuscitation periods (P < 0.05). Delta (R-SP), a measure of thrombin generation, showed a significant increase (P < 0.05) from baseline to shock. No significant changes were found in K, Angle, MA, and LY30 values. CONCLUSION: Clotting factor derangement leading to impaired thrombin generation is the principle etiology of ACOT in this model and not the dynamics of clot formation, fibrin cross-linking, clot strength/platelet function, or fibrinolysis.
BACKGROUND: Acute coagulopathy of trauma (ACOT) has been described as a very early hypocoagulable state, but the mechanism remains controversial. One proposed mechanism is tissue hypoperfusion leading to protein C activation, with subsequent inhibition of Factors V and VIII. Variability in trauma has impeded the use of clinical data towards the elucidation of the mechanisms of ACOT, but thrombelastography (TEG) may provide insight by assessing hemostatic function from initial thrombin activation to fibrinolysis. We hypothesized that in a controlled animal model of trauma/hemorrhagic shock, clotting factor dysfunction is the predominant mechanism in early ACOT. METHODS:Rats anesthetized by inhaled isoflurane (n = 6) underwent laparotomy, and hemorrhage was induced to maintain a MAP of 35 mm Hg for 30 min. Rats were then resuscitated with twice their shed blood volume in normal saline. TEG was performed at baseline, shock, and post-resuscitation periods. No heparin was given. Statistical analysis was performed by ANOVA with post-hoc Fisher's test. RESULTS: Coagulation factor function was significantly impaired in the early stages of trauma/hemorrhagic shock. TEG R and SP-values were significantly increased from baseline to shock (P < 0.001) and from shock to post-resuscitation periods (P < 0.05). Delta (R-SP), a measure of thrombin generation, showed a significant increase (P < 0.05) from baseline to shock. No significant changes were found in K, Angle, MA, and LY30 values. CONCLUSION: Clotting factor derangement leading to impaired thrombin generation is the principle etiology of ACOT in this model and not the dynamics of clot formation, fibrin cross-linking, clot strength/platelet function, or fibrinolysis.
Authors: Roger C Carroll; Robert M Craft; Russell J Langdon; Colin R Clanton; Carolyn C Snider; Douglas D Wellons; Patrick A Dakin; Christy M Lawson; Blaine L Enderson; Stanley J Kurek Journal: Transl Res Date: 2009-05-03 Impact factor: 7.012
Authors: Pär I Johansson; Trine Stissing; Louise Bochsen; Sisse R Ostrowski Journal: Scand J Trauma Resusc Emerg Med Date: 2009-09-23 Impact factor: 2.953
Authors: Benjamin Michael Howard; Lucy Z Kornblith; Brittney J Redick; Amanda S Conroy; Mary F Nelson; Carolyn S Calfee; Rachael A Callcut; Mitchell Jay Cohen Journal: J Trauma Acute Care Surg Date: 2018-01 Impact factor: 3.313
Authors: Alexis L Cralley; Ernest E Moore; Daniel Kissau; Julia R Coleman; Navin Vigneshwar; Margot DeBot; Terry R Schaid; Hunter B Moore; Mitchell J Cohen; Kirk Hansen; Christopher C Silliman; Angela Sauaia; Charles J Fox Journal: J Trauma Acute Care Surg Date: 2022-05-12 Impact factor: 3.697
Authors: Hannah V Hayes; Molly E Droege; Craig J Furnish; Michael D Goodman; Neil E Ernst; Christopher A Droege Journal: Surg Open Sci Date: 2020-04-14
Authors: Douglas Z Liou; Ara Ko; Oksana Volod; Galinos Barmparas; Megan Y Harada; Matthew J Martin; Ali Salim; Navpreet Dhillon; Gretchen M Thomsen; Eric J Ley Journal: Neurocrit Care Date: 2016-08 Impact factor: 3.210
Authors: Margaret R Passmore; Nchafatso G Obonyo; Liam Byrne; Ai-Ching Boon; Sara D Diab; Kimble R Dunster; Yoke L Fung; Michelle M Spanevello; Mohd H Fauzi; Sanne E Pedersen; Gabriela Simonova; Chris M Anstey; Kiran Shekar; John-Paul Tung; Kathryn Maitland; John F Fraser Journal: Thromb Res Date: 2019-02-12 Impact factor: 10.407
Authors: Benjamin M Howard; Lucy Z Kornblith; Christopher K Cheung; Matthew E Kutcher; Byron Y Miyazawa; Ryan F Vilardi; Mitchell J Cohen Journal: PLoS One Date: 2016-03-23 Impact factor: 3.240
Authors: Oliver Grottke; James Aisenberg; Richard Bernstein; Patrick Goldstein; Menno V Huisman; Dara G Jamieson; Jerrold H Levy; Charles V Pollack; Alex C Spyropoulos; Thorsten Steiner; Gregory J Del Zoppo; John Eikelboom Journal: Crit Care Date: 2016-04-28 Impact factor: 9.097